Five Themes Set to Dominate the Year Ahead – and How to Prepare
As we approach the New Year, a range of disruptive forces present distinct challenges for investors – playing out in the geopolitical arena in the form of trade wars, on the policy front in the form of divergent monetary policies, and on the economic front as countries contend with a late cycle environment.
How minimum variance strategies have performed in US downturn
After years of low volatility, equity risk may be returning once again – with several larger movements this year emanating from the USA. For risk averse investors, low volatility equity strategies have offered the chance for investors to moderate the volatility.
Demand for Growth Creates Opportunities for Value in EM
The incessant investor demand for exposure to new economy sectors has driven valuations of the emerging world’s high growth companies to historical levels. Furthermore, investors have ignored traditional value sectors, driving the divergence of valuations between new and old economy stocks to new highs. For Value investors, this has created many areas that are being overlooked or forgotten.
Greater interest in the biotech sector
There was a positive flow of capital into the biotech sector during the third quarter.BB Biotech is actively increasing its exposure to new drug development technology such as RNA-based therapeutic agents, and gene and cell-based therapies.
Infographic: What styles still work for US equity?
US equity is a tricky market for stockpickers. The world’s biggest stock market is one of the most researched. This means few opportunities are missed, here’s not much left for the value seeker.